Early Experience with Hypothermic Machine Perfusion of Living Donor Kidneys

Moser et al. sought to determine whether the short warm ischemic time in living donor kidney (LDK) transplantation causes damage to the kidney, and whether these kidneys could benefit from the use of hypothermic machine perfusion (HMP). In their initial experiment, they compared the results of 16 LDK kidneys that were placed on HMP to historical controls.  

They found that:

  • The perfusate had significant injury markers in the perfusates of the LDK kidneys
    • Suggesting damage during the normothermic ischemia period
  • Creatinine clearance was significantly higher in the HMP group at post-operative day 2 and persisted at one-year post-transplant
  • The vascular resistance improved during HMP and this persisted in the early post-operative period  
    • The resistive indices were significantly less for the HMP group than the static cold storage group

They noted that the significant levels of injury markers in perfusate of the LDK after a short preservation time suggests that injury does occur in this procedure.  They concluded that their early experience suggests that HMP may be beneficial to LDK in terms of early changes to vascular resistance and early function.

Read the full article here: https://onlinelibrary.wiley.com/doi/full/10.1111/tri.12964

The Latest

Check out the most recent posts

Katie, Strategic Account Manager

Katie, Strategic Account Manager

My connection to donation and transplantation began with my uncle’s heart transplant in 2002. Since 2011, I’ve served the field through roles in organ procurement, transplant nursing, service line leadership, and industry support for diagnostics and immunosuppressive...

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...